Screener
ANI Pharmaceuticals ANIP EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from ANI Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
FAQ
- What is ANI Pharmaceuticals's EV / EBITDA?
- ANI Pharmaceuticals (ANIP) reported EV / EBITDA of 7.7× in Q2 2026.
- How has ANI Pharmaceuticals's EV / EBITDA changed year-over-year?
- ANI Pharmaceuticals's EV / EBITDA decreased by 57.9% year-over-year, from 18.3× to 7.7×.
- What is the long-term trend for ANI Pharmaceuticals's EV / EBITDA?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's EV / EBITDA has grown at a -17.3% compound annual growth rate (CAGR), from 23.1× to 8.9×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about ANI Pharmaceuticals's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude